1Lane KB,Machado RD,Pauciulo MW,et al.Heterozygous germline mutations in BMPR2,encoding a TGF-beta receptor,cause familial primary pulmonary hypertension.Nat Genet,2000,26(1):81-84.
2Thomson JR,Machado RD,Pauciulo MW,et al.Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II,a receptor member of the TGF-beta family.J Med Genet,2000,37(10):741-745.
7Wilkens H,Guth A,Konig J,et al.Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.Circulation,2001,104(11):1218-1222.
8Rich S,McLaughlin VV.The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension.J Am Coll Cardiol,1999,34(4):1184-1187.
9Hoeper MM,Olschewski H,Ghofrani HA,et al.A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension.J Am Coll Cardiol,2000,35(1):176-182.
10Hoeper MM,Schwarze M,Ehlerding S,et al.Long-term treatment of primary pulmonary hypertension with aerosolized iloprost,a prostacyclin analogue.N Engl J Med,2000,342(25):1866-1870.
4Rubin L. Diagnosis and management of pulmonary arterial hypertension: ACCPevidence - based clinical practice guidelines [J]. Chest, 2004, 126: 7.
5Galie N, Torbieki A, Barst R, et al. Guidelines on diagnosis and treawaent of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hy-pertension of the European Socity of Cardiology[J]. Eur Heart J, 2004, 25: 2243.
6McLaughlin V V, Archer S L, Badesch D B, et al. ACCF/ AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Cheat Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association [J]. Circulation, 2009, 119: 2250.
7Rubin L.Diagnosis and management of pulmonary arterial hypertension:ACCP evidence-based clinical practice guidelines[J].Chest,2004,126:7-10.
8陈灏洙.心脏病学--心血管内科学教科书[M].北京:人民卫生出版社,2000.724.
9Rich S,Kaufman E,Lery P.The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension[J].N Engl J Med,1992,327(1):76.
10Hoeper MM,Olschewki H,Ghofrani HA,et al.A comparison of the hemodynamic effects of inhaled nisteric oxide and aerosolized iloprost in primary pulmonary[J].J Am Coll Cardiol,2000,35(1):176-182.
